Cargando…
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
Vitamin A is required for important physiological processes, including embryogenesis, vision, cell proliferation and differentiation, immune regulation, and glucose and lipid metabolism. Many of vitamin A’s functions are executed through retinoic acids that activate transcriptional networks controll...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793257/ https://www.ncbi.nlm.nih.gov/pubmed/29286303 http://dx.doi.org/10.3390/nu10010029 |
_version_ | 1783296909712031744 |
---|---|
author | Saeed, Ali Dullaart, Robin P. F. Schreuder, Tim C. M. A. Blokzijl, Hans Faber, Klaas Nico |
author_facet | Saeed, Ali Dullaart, Robin P. F. Schreuder, Tim C. M. A. Blokzijl, Hans Faber, Klaas Nico |
author_sort | Saeed, Ali |
collection | PubMed |
description | Vitamin A is required for important physiological processes, including embryogenesis, vision, cell proliferation and differentiation, immune regulation, and glucose and lipid metabolism. Many of vitamin A’s functions are executed through retinoic acids that activate transcriptional networks controlled by retinoic acid receptors (RARs) and retinoid X receptors (RXRs).The liver plays a central role in vitamin A metabolism: (1) it produces bile supporting efficient intestinal absorption of fat-soluble nutrients like vitamin A; (2) it produces retinol binding protein 4 (RBP4) that distributes vitamin A, as retinol, to peripheral tissues; and (3) it harbors the largest body supply of vitamin A, mostly as retinyl esters, in hepatic stellate cells (HSCs). In times of inadequate dietary intake, the liver maintains stable circulating retinol levels of approximately 2 μmol/L, sufficient to provide the body with this vitamin for months. Liver diseases, in particular those leading to fibrosis and cirrhosis, are associated with impaired vitamin A homeostasis and may lead to vitamin A deficiency. Liver injury triggers HSCs to transdifferentiate to myofibroblasts that produce excessive amounts of extracellular matrix, leading to fibrosis. HSCs lose the retinyl ester stores in this process, ultimately leading to vitamin A deficiency. Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a spectrum of conditions ranging from benign hepatic steatosis to non-alcoholic steatohepatitis (NASH); it may progress to cirrhosis and liver cancer. NASH is projected to be the main cause of liver failure in the near future. Retinoic acids are key regulators of glucose and lipid metabolism in the liver and adipose tissue, but it is unknown whether impaired vitamin A homeostasis contributes to or suppresses the development of NAFLD. A genetic variant of patatin-like phospholipase domain-containing 3 (PNPLA3-I148M) is the most prominent heritable factor associated with NAFLD. Interestingly, PNPLA3 harbors retinyl ester hydrolase activity and PNPLA3-I148M is associated with low serum retinol level, but enhanced retinyl esters in the liver of NAFLD patients. Low circulating retinol in NAFLD may therefore not reflect true “vitamin A deficiency”, but rather disturbed vitamin A metabolism. Here, we summarize current knowledge about vitamin A metabolism in NAFLD and its putative role in the progression of liver disease, as well as the therapeutic potential of vitamin A metabolites. |
format | Online Article Text |
id | pubmed-5793257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57932572018-02-06 Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) Saeed, Ali Dullaart, Robin P. F. Schreuder, Tim C. M. A. Blokzijl, Hans Faber, Klaas Nico Nutrients Review Vitamin A is required for important physiological processes, including embryogenesis, vision, cell proliferation and differentiation, immune regulation, and glucose and lipid metabolism. Many of vitamin A’s functions are executed through retinoic acids that activate transcriptional networks controlled by retinoic acid receptors (RARs) and retinoid X receptors (RXRs).The liver plays a central role in vitamin A metabolism: (1) it produces bile supporting efficient intestinal absorption of fat-soluble nutrients like vitamin A; (2) it produces retinol binding protein 4 (RBP4) that distributes vitamin A, as retinol, to peripheral tissues; and (3) it harbors the largest body supply of vitamin A, mostly as retinyl esters, in hepatic stellate cells (HSCs). In times of inadequate dietary intake, the liver maintains stable circulating retinol levels of approximately 2 μmol/L, sufficient to provide the body with this vitamin for months. Liver diseases, in particular those leading to fibrosis and cirrhosis, are associated with impaired vitamin A homeostasis and may lead to vitamin A deficiency. Liver injury triggers HSCs to transdifferentiate to myofibroblasts that produce excessive amounts of extracellular matrix, leading to fibrosis. HSCs lose the retinyl ester stores in this process, ultimately leading to vitamin A deficiency. Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a spectrum of conditions ranging from benign hepatic steatosis to non-alcoholic steatohepatitis (NASH); it may progress to cirrhosis and liver cancer. NASH is projected to be the main cause of liver failure in the near future. Retinoic acids are key regulators of glucose and lipid metabolism in the liver and adipose tissue, but it is unknown whether impaired vitamin A homeostasis contributes to or suppresses the development of NAFLD. A genetic variant of patatin-like phospholipase domain-containing 3 (PNPLA3-I148M) is the most prominent heritable factor associated with NAFLD. Interestingly, PNPLA3 harbors retinyl ester hydrolase activity and PNPLA3-I148M is associated with low serum retinol level, but enhanced retinyl esters in the liver of NAFLD patients. Low circulating retinol in NAFLD may therefore not reflect true “vitamin A deficiency”, but rather disturbed vitamin A metabolism. Here, we summarize current knowledge about vitamin A metabolism in NAFLD and its putative role in the progression of liver disease, as well as the therapeutic potential of vitamin A metabolites. MDPI 2017-12-29 /pmc/articles/PMC5793257/ /pubmed/29286303 http://dx.doi.org/10.3390/nu10010029 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Saeed, Ali Dullaart, Robin P. F. Schreuder, Tim C. M. A. Blokzijl, Hans Faber, Klaas Nico Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title_full | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title_fullStr | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title_full_unstemmed | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title_short | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD) |
title_sort | disturbed vitamin a metabolism in non-alcoholic fatty liver disease (nafld) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793257/ https://www.ncbi.nlm.nih.gov/pubmed/29286303 http://dx.doi.org/10.3390/nu10010029 |
work_keys_str_mv | AT saeedali disturbedvitaminametabolisminnonalcoholicfattyliverdiseasenafld AT dullaartrobinpf disturbedvitaminametabolisminnonalcoholicfattyliverdiseasenafld AT schreudertimcma disturbedvitaminametabolisminnonalcoholicfattyliverdiseasenafld AT blokzijlhans disturbedvitaminametabolisminnonalcoholicfattyliverdiseasenafld AT faberklaasnico disturbedvitaminametabolisminnonalcoholicfattyliverdiseasenafld |